Table 1 Study cohort demographics of the schizophrenia and control participants
From: Progressive trajectories of schizophrenia across symptoms, genes, and the brain
Characteristic | Schizophrenia (n = 86) | HC (n = 120) | P-value |
|---|---|---|---|
Age (years) | 40.66 ± 11.17 | 37.73 ± 14.69 | 0.12 |
Gender (M:F) | 61:25 | 80:40 | 0.52 |
Education | 11.45 ± 2.59 | 11.07 ± 3.08 | 0.36 |
Duration (years) | 15.22 ± 10.20 | – | – |
Chlorpromazine equivalents (mg/day) | 337.96 ± 144.41 | – | – |
PANSS score | |||
 Total | 62.21 ± 13.16 | – | – |
 Positive | 13.32 ± 5.84 | – | – |
 Negative | 20.70 ± 6.01 | – | – |
 General | 28.19 ± 5.81 | – | – |